Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 12324843
Compositions and methods for delivery of biomacromolecule agents
granted -
US 12325752
Immunoglobulin proteins that bind to NPR1 agonists
granted -
WO 2025114603
COMBINAISONS PHARMACEUTIQUES DESTINÉES À ÊTRE UTILISÉES DANS LE TRAITEMENT D'INFECTIONS FONGIQUES
granted -
WO 2025114430
COMPOSITION À LIBÉRATION MODIFIÉE
granted -
WO 2025114529
ANTICORPS MULTISPÉCIFIQUES RECONNAISSANT L'ALBUMINE SÉRIQUE HUMAINE, TCR ET FRACTION RECONNAISSANT L'ANTIGÈNE TUMORAL
granted -
EP 4563165
PSMA-STEAP1-IMMUNGLOBULIN (DVD-IG)-MOLEKÜLE MIT ZWEIFACH VARIABLER DOMÄNE UND ARZNEIMITTELKONJUGATE
granted -
US 12318386
Combination of XPO1 inhibitors and second agents for the treatment of prostate cancer
granted -
US 12318376
Compositions of a polyorthoester and an aprotic solvent
granted -
US 12318375
Method of treatment with tradipitant
granted -
US 12318397
Methods and compositions for testosterone production
granted -
US 12318362
Methods of providing solriamfetol therapy to subjects with impaired renal function
granted -
US 12318418
Modified adenoviruses
granted -
US 12318401
Injectable shear-thinning hydrogel containing therapeutic agent for enhanced tumor therapy
granted -
US 12318426
Compositions and methods for the treatment of metabolic and liver disorders
granted -
US 12319738
Anti-FGFR2 antibodies in combination with chemotherapy agents in gastric cancer
granted -
US 12319703
Macrocyclic fused pyrazoles as Mcl-1 inhibitors
granted -
US 12318454
Bicyclic peptide ligands specific for MT1-MMP
granted -
US 12318457
Oligosaccharide linker, linker-payload comprising the same and glycan chain-remodeled antibody-drug conjugate, preparation methods and uses thereof
granted -
US 12319724
IL2 agonists and methods of use thereof
granted -
US 12318427
Methods and compositions for modulation of tau proteins
granted -
US 12318364
Isoflavonoid compositions and methods for the treatment of cancer
granted -
US 12318483
Manufacturing of bupivacaine multivesicular liposomes
granted -
US 12319684
Agonists of the apelin receptor and methods of use thereof
granted -
US 12319708
Agonists of peroxisome proliferator-activated receptor alpha (PPARα) and methods of use
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.